Davis's Drug Guide
crinecerfont
General
Pronunciation:
kri-ne-ser-font
Trade Name(s)
- Crenessity
Ther. Class.
none assigned
Pharm. Class.
temporary class
corticotropin-releasing factor type 1 receptor antagonistThere's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Crinecerfont." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2026. www.drugguide.com/ddo/view/Davis-Drug-Guide/3580041/all/crinecerfont.
Vallerand AHA, Sanoski CAC, . Crinecerfont. Davis's Drug Guide. F.A. Davis Company; 2026. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/3580041/all/crinecerfont. Accessed June 2, 2026.
Vallerand, A. H., Sanoski, C. A., & , (2026). Crinecerfont. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/3580041/all/crinecerfont
Vallerand AHA, Sanoski CAC, . Crinecerfont [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 June 02]. Available from: https://www.drugguide.com/ddo/view/Davis-Drug-Guide/3580041/all/crinecerfont.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - crinecerfont
ID - 3580041
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://www.drugguide.com/ddo/view/Davis-Drug-Guide/3580041/all/crinecerfont
PB - F.A. Davis Company
ET - 19
DB - Davis's Drug Guide
DP - Unbound Medicine
ER -